Literature DB >> 8692735

Non steady-state descriptions of drug permeation through stratum corneum. I. The biphasic brick-and-mortar model.

M Heisig1, R Lieckfeldt, G Wittum, G Mazurkevich, G Lee.   

Abstract

PURPOSE: The diffusion equation should be solved for the non-steady-state problem of drug diffusion within a two-dimensional, biphasic stratum corneum membrane having homogeneous lipid and corneocyte phases.
METHODS: A numerical method was developed for a brick-and-mortar SC-geometry, enabling an explicit solution for time-dependent drug concentration within both phases. The lag time and permeability were calculated.
RESULTS: It is shown how the barrier property of this model membrane depends on relative phase permeability, corneocyte alignment, and corneocyte-lipid partition coefficient. Additionally, the time-dependent drug concentration profiles within the membrane can be observed during the lag and steady-state phases.
CONCLUSIONS: The model SC-membrane predicts, from purely morphological principles, lag times and permeabilities that are in good agreement with experimental values. The long lag times and very small permeabilities reported for human SC can only be predicted for a highly-staggered corneocyte geometry and corneocytes that are 1000 times less permeable than the lipid phase. Although the former conclusion is reasonable, the latter is questionable. The elongated, flattened corneocyte shape renders lag time and permeability insensitive to large changes in their alignment within the SC. Corneocyte/lipid partitioning is found to be fundamentally different to SC/donor partitioning, since increasing drug lipophilicity always reduces both lag time and permeability.

Entities:  

Mesh:

Year:  1996        PMID: 8692735     DOI: 10.1023/a:1016048710880

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

1.  Random brick model for drug transport across stratum corneum.

Authors:  K Tojo
Journal:  J Pharm Sci       Date:  1987-12       Impact factor: 3.534

2.  A linear theory of transdermal transport phenomena.

Authors:  D A Edwards; R Langer
Journal:  J Pharm Sci       Date:  1994-09       Impact factor: 3.534

3.  Percutaneous absorption: in vivo experiments.

Authors:  W J Albery; J Hadgraft
Journal:  J Pharm Pharmacol       Date:  1979-03       Impact factor: 3.765

4.  Diffusivity and structural polymorphism in some model stratum corneum lipid systems.

Authors:  R Lieckfeldt; J Villalain; J C Gomez-Fernandez; G Lee
Journal:  Biochim Biophys Acta       Date:  1993-08-15

5.  Improved barrier structure formation in air-exposed human keratinocyte culture systems.

Authors:  M Fartasch; M Ponec
Journal:  J Invest Dermatol       Date:  1994-03       Impact factor: 8.551

6.  Evidence that the corneocyte has a chemically bound lipid envelope.

Authors:  D C Swartzendruber; P W Wertz; K C Madison; D T Downing
Journal:  J Invest Dermatol       Date:  1987-06       Impact factor: 8.551

7.  Correlation of specific keratins with different types of epithelial differentiation: monoclonal antibody studies.

Authors:  S C Tseng; M J Jarvinen; W G Nelson; J W Huang; J Woodcock-Mitchell; T T Sun
Journal:  Cell       Date:  1982-09       Impact factor: 41.582

8.  Human stratum corneum lipids: characterization and regional variations.

Authors:  M A Lampe; A L Burlingame; J Whitney; M L Williams; B E Brown; E Roitman; P M Elias
Journal:  J Lipid Res       Date:  1983-02       Impact factor: 5.922

Review 9.  A domain mosaic model of the skin barrier.

Authors:  B Forslind
Journal:  Acta Derm Venereol       Date:  1994-01       Impact factor: 4.437

  9 in total
  10 in total

1.  A study on structural and diffusion properties of porcine stratum corneum based on very small angle neutron scattering data.

Authors:  G C Charalambopoulou; P Karamertzanis; E S Kikkinides; A K Stubos; N K Kanellopoulos; A T Papaioannou
Journal:  Pharm Res       Date:  2000-09       Impact factor: 4.200

2.  Visualization of the lipid barrier and measurement of lipid pathlength in human stratum corneum.

Authors:  P Talreja; N K Kleene; W L Pickens; T F Wang; G B Kasting
Journal:  AAPS PharmSci       Date:  2001

Review 3.  Lipophilicity and its relationship with passive drug permeation.

Authors:  Xiangli Liu; Bernard Testa; Alfred Fahr
Journal:  Pharm Res       Date:  2010-10-30       Impact factor: 4.200

Review 4.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

Review 5.  Getting Drugs Across Biological Barriers.

Authors:  Rong Yang; Tuo Wei; Hannah Goldberg; Weiping Wang; Kathleen Cullion; Daniel S Kohane
Journal:  Adv Mater       Date:  2017-07-28       Impact factor: 30.849

6.  Effect of stratum corneum heterogeneity, anisotropy, asymmetry and follicular pathway on transdermal penetration.

Authors:  Ana M Barbero; H Frederick Frasch
Journal:  J Control Release       Date:  2017-06-29       Impact factor: 9.776

7.  A novel approach to modelling water transport and drug diffusion through the stratum corneum.

Authors:  Tatiana T Marquez-Lago; Diana M Allen; Jenifer Thewalt
Journal:  Theor Biol Med Model       Date:  2010-08-17       Impact factor: 2.432

8.  The role of corneocytes in skin transport revised--a combined computational and experimental approach.

Authors:  Steffi Hansen; Arne Naegel; Michael Heisig; Gabriel Wittum; Dirk Neumann; Karl-Heinz Kostka; Peter Meiers; Claus-Michael Lehr; Ulrich F Schaefer
Journal:  Pharm Res       Date:  2009-02-25       Impact factor: 4.200

9.  Tortuosity of Aligned Channels in Alumina Membranes Produced by Vacuum-Induced Surface Directional Freezing.

Authors:  Sandra Großberger; Tobias Fey; Geoffrey Lee
Journal:  Materials (Basel)       Date:  2017-04-14       Impact factor: 3.623

Review 10.  Surging footprints of mathematical modeling for prediction of transdermal permeability.

Authors:  Neha Goyal; Purva Thatai; Bharti Sapra
Journal:  Asian J Pharm Sci       Date:  2017-02-22       Impact factor: 6.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.